Back to search

Aristotle University Of Thessaloniki (AUTH)

Η αλληλεπίδραση των αναστολέων των πρωτεϊνικών τυροσινικών κινασών με κυτταροστατικά φάρμακα σε κυτταροκαλλιέργειες

Abstract

dc:description

Protein tyrosine kinases (PTKs) play a crucial role in regulating cellular proliferation, differentiation and apoptosis. New drugs are already entering clinical trials and everyday clinical practice, inhibiting several PTK families. The demand for better therapies in the future will introduce new combination therapies, possibly combining traditional chemotherapeutic drugs with new signal transduction inhibitors. The purpose of this study was to evaluate the combined activity of PTK-inhibitors and chemotherapy in in vitro culture systems and to investigate the possible mechanism of action of such a combination. The three basic points to be addressed were the following: 1. What is the final result of the combination between PTK inhibitors and chemotherapy? Two classes of chemotherapeutic drugs were used, taxanes (agents that act in microtubules and promote death deregulating the mitotic spindle formation) and camptothecins that induce DNA damage in S-phase. The cell lines used were HeLa (cervical cancer), OAW-42 (ovarian cancer), HT29 (colon cancer) and L929 (normal mouse fibroblasts). Paclitaxel and PTK-inhibitor genistein exhibited an antagonistic effect. However, in certain PTK inhibitor-sensitive cells, this antagonism was not so strong, leaving some space for combination of the two drugs. However, genistein and herbimycin-A exhibited a strong synergistic effect in combination with the camptothecins irinotecan and topotecan in all cell lines except HT29 colon cancer cells. 2. What is the influence of PTK inhibitors on the two endpoints of the chemotherapy effect: cytostatic effect (DNA synthesis and cell cycle inhibition) and cytotoxic effect (apoptosis induction). Genistein antagonized the cytostatic effects of irinotecan (though the combination results in synergism in the overall result). Irinotecan induced G2 -phase arrest and this was inhibited by genistein in HeLa and OAW-42 cells. The inhibition of DNA synthesis and G2-phase arrest could be possibly explained by a deregulation of the G2-checkpoint, a pathway that keeps cells out of the cell cycle after DNA damage in order to repair the damage and re-ender cell cycle (in mitosis). This was confirmed with DNAelectrophoresis and PARP (poly[ADP-ribose]polymerase) cleavage experiments, where it was shown (for HeLa and OAW-42 cells) that genistein enhanced apoptosis induced by irinotecan. We hypothesized that a deregulation of G2-checkpoint (and possibly of the other pathways that inhibit cell cycle progression as well) could be one of the mechanisms to explain the antagonism in DNA synthesis and the augmentation of apoptosis. 3. What is the effect of PTK inhibitor genistein on cell survival pathways after DNA damage? DNA damage can induce apoptosis. However there are multiple signals inhibiting apoptotic pathways, that a cell can induce in order to survive and continue living and proliferating. It was experimentally confirmed that genistein did not affect p21WAF1 and bcl-2 expression, neither had any effect on MAPK kinase activation, three of the anti-apoptotic pathways. However it inhibited nuclear translocation of p50/NFxB (in HeLa and L929 cells) and tyrosine phosphorylation of CDK-1 (p34cdc"2), deregulating G2 checkpoint and increasing apoptosis. It was also shown that genistein downregulated p27KIP1 expression. The conclusion is that PTK inhibitors have a synergistic effect when combined with camptothecins. This synergism can be attributed to the inhibition (by PTK-inhibitors) of the cell cycle arrest and survival pathways after DNA damage induced by camptothecins.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2002

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Παπαζήσης, Κωνσταντίνος
  • Papazisis, Konstantinos

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/13372

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Παπαζήσης, Κωνσταντίνος; Papazisis, Konstantinos. Η αλληλεπίδραση των αναστολέων των πρωτεϊνικών τυροσινικών κινασών με κυτταροστατικά φάρμακα σε κυτταροκαλλιέργειες. Aristotle University Of Thessaloniki (AUTH), 2002. http://hdl.handle.net/10442/hedi/13372